INTRODUCTION: Reasoning biases such as jumping to conclusions (JTC) and overconfidence in errors have been well replicated in patients with delusions. However, their relation to dopaminergic activity, central to pathophysiologic models of psychosis, has not yet been investigated. This study aimed to examine the effects of a dopaminergic agonist (L-dopa) and a dopaminergic antagonist (haloperidol) on the JTC bias and overconfidence in errors after single-dose administration in healthy individuals. METHODS: The study used a randomized, double-blind, placebo-controlled, 3-way crossover design. Participants were 36 healthy individuals aged 18-36 years. The variables of interest were draws to decision and probability threshold to decision on a computerized variant of the beads task and the number of high-confident incorrect responses on a visual memory task. RESULTS: There were no significant effects of substance on draws to decision and probability threshold to decision. A significant effect emerged for high-confident incorrect responses in the memory task; pairwise comparisons indicated a significant reduction of the number of high-confident incorrect responses after administration of haloperidol vs l-dopa and placebo. CONCLUSIONS: This is the first study to investigate the direct effects of dopaminergic drugs on reasoning biases. The JTC bias and overconfidence in errors showed a differential pattern of dopaminergic modulation, suggesting that they represent different facets of reasoning abnormalities that interact with each other to produce delusions in susceptible individuals.
RCT Entities:
INTRODUCTION: Reasoning biases such as jumping to conclusions (JTC) and overconfidence in errors have been well replicated in patients with delusions. However, their relation to dopaminergic activity, central to pathophysiologic models of psychosis, has not yet been investigated. This study aimed to examine the effects of a dopaminergic agonist (L-dopa) and a dopaminergic antagonist (haloperidol) on the JTC bias and overconfidence in errors after single-dose administration in healthy individuals. METHODS: The study used a randomized, double-blind, placebo-controlled, 3-way crossover design. Participants were 36 healthy individuals aged 18-36 years. The variables of interest were draws to decision and probability threshold to decision on a computerized variant of the beads task and the number of high-confident incorrect responses on a visual memory task. RESULTS: There were no significant effects of substance on draws to decision and probability threshold to decision. A significant effect emerged for high-confident incorrect responses in the memory task; pairwise comparisons indicated a significant reduction of the number of high-confident incorrect responses after administration of haloperidol vs l-dopa and placebo. CONCLUSIONS: This is the first study to investigate the direct effects of dopaminergic drugs on reasoning biases. The JTC bias and overconfidence in errors showed a differential pattern of dopaminergic modulation, suggesting that they represent different facets of reasoning abnormalities that interact with each other to produce delusions in susceptible individuals.
Entities:
Keywords:
delusions; jumping to conclusions; liberal acceptance; metacognition; reasoning biases; schizophrenia
Authors: Philippa A Garety; Daniel Freeman; Suzanne Jolley; Graham Dunn; Paul E Bebbington; David G Fowler; Elizabeth Kuipers; Robert Dudley Journal: J Abnorm Psychol Date: 2005-08
Authors: Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon Journal: J Neurosci Date: 2009-06-03 Impact factor: 6.167
Authors: S Silvestri; M V Seeman; J C Negrete; S Houle; C M Shammi; G J Remington; S Kapur; R B Zipursky; A A Wilson; B K Christensen; P Seeman Journal: Psychopharmacology (Berl) Date: 2000-10 Impact factor: 4.530
Authors: Anthony J Angwin; Helen J Chenery; David A Copland; Wendy L Arnott; Bruce E Murdoch; Peter A Silburn Journal: J Int Neuropsychol Soc Date: 2004-01 Impact factor: 2.892
Authors: M R Broome; L C Johns; I Valli; J B Woolley; P Tabraham; C Brett; L Valmaggia; E Peters; P A Garety; P K McGuire Journal: Br J Psychiatry Suppl Date: 2007-12
Authors: Bruno B Averbeck; Simon Evans; Viraj Chouhan; Eleanor Bristow; Sukhwinder S Shergill Journal: Schizophr Res Date: 2011-04 Impact factor: 4.939
Authors: Suzanne H So; Daniel Freeman; Graham Dunn; Shitij Kapur; Elizabeth Kuipers; Paul Bebbington; David Fowler; Philippa A Garety Journal: J Abnorm Psychol Date: 2011-09-12
Authors: Christina Andreou; Brooke C Schneider; Vivien Braun; Katharina Kolbeck; Jürgen Gallinat; Steffen Moritz Journal: J Psychiatry Neurosci Date: 2015-11 Impact factor: 6.186
Authors: Anna O Ermakova; Pranathi Ramachandra; Philip R Corlett; Paul C Fletcher; Graham K Murray Journal: PLoS One Date: 2014-07-25 Impact factor: 3.240
Authors: Suzanne Jolley; Claire Thompson; James Hurley; Evelina Medin; Lucy Butler; Paul Bebbington; Graham Dunn; Daniel Freeman; David Fowler; Elizabeth Kuipers; Philippa Garety Journal: Psychiatry Res Date: 2014-06-04 Impact factor: 3.222
Authors: Raquel Vicario-Feliciano; Rebekah L Wigton; Thomas P White; Sukhi S Shergill; Bruno B Averbeck Journal: J Psychopharmacol Date: 2019-01-15 Impact factor: 4.153